Abstract
The surfacing of the applied fields of biology such as, biotechnology, pharmacology and drug discovery was a boon to the modern man. However, it had its share of disadvantages too. The indiscriminate use of antibiotics and other biological drugs resulted in numerous adverse reactions including thrombocytopenia. One of the reasons for drug-induced thrombocytopenia could be attributed to an enhanced rate of platelet apoptosis, which is a less investigated aspect. The present essay sheds light on the adverse (pro-apoptotic) effects of some of the commonly used drugs and antibiotics on platelets viz. cisplatin, aspirin, vancomycin and balhimycin. Furthermore, the undesirable reactions resulting from chemotherapy could be attributed at least to some extent to the systemic stress induced by microparticles, which in turn are the byproducts of platelet apoptosis. Thereby, the essay aims to highlight the challenges in the emerging trend of cross-disciplinary implications, i.e., drug-induced platelet apoptosis, which is a nascent field. Thus, the different mechanisms through which drugs induce platelet apoptosis are discussed, which also opens up a new perspective through which the adverse effects of commonly used drugs could be dealt. The drug-associated platelet toxicity is of grave concern and demands immediate attention. Besides, it would also be appealing to examine the platelet pro-apoptotic effects of other commonly used therapeutic drugs.
Similar content being viewed by others
References
Ahn YS, Jy W, Jimenez JJ, Horstman LL (2004) More on: cellular microparticles: what are they bad or good for? J Thromb Haemost 2:1215–1216
Antoniak S, Boltzen U, Eisenreich A, Stellbaum C, Poller W, Schultheiss HP, Rauch U (2009) Regulation of cardiomyocyte full-length tissue factor expression and microparticle release under inflammatory conditions in vitro. J Thromb Haemost 7:871–878
Aster RH, Curtis BR, McFarland JG, Bougie DW (2009) Drug induced thrombocytopenia: pathogenesis, diagnosis and management. J Thromb Haemost 7:911–918
Barabas K, Milner R, Lurie D, Adin C (2008) Cisplatin: a review of toxicities and therapeutic applications. Vet Comp Oncol 6:1–18
Boilard E, Nigrovic PA, Larabee K, Watts GF, Coblyn JS, Weinblatt ME, Massarotti EM, Remold-O’Donnell E, Farndale RW, Ware J, Lee DM (2010) Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science 327:580–583
Bonomini M, Dottori S, Amoroso L, Arduini A, Sirolli V (2004) Increased platelet phosphatidylserine exposure and caspase activation in chronic uremia. J Thromb Haemost 2:1275–1281
Burger D, Schock S, Thompson CS, Montezano AC, Hakim AM, Touyz RM (2013) Microparticles: biomarkers and beyond. Clin Sci (Lond) 124:423–441
Candemir B, Aribuca A, Koca C, Ozcan OU, Gerede M, Kaya CT (2012) An unusual case of vancomycin-related systemic reaction accompanied with severe thrombocytopenia mimicking pacemaker-related infective endocarditis: a case report and review of literature. J Interv Card Electrophysiol 38(2):143–145
Chatterjee S, Vijayakumar EKS, Nadkarni SR, Patel MV, Blumbach J, Ganguli BN (1994) Balhimycin a new glycopeptide antibiotic with an unusual hydrated 3-amino-4-oxoaldopyranose sugar moiety. Org Chem 59:3480–3484
Coleman ML, Sahai EA, Yeo M, Bosch M, Dewar A, Olson MF (2001) Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I. Nat Cell Biol 3:339–345
Cory S, Adams JM (2002) The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2:647–656
Creagh EM, Martin SJ (2001) Caspases: cellular demolition experts. Biochem Soc Trans 29:696–702
Danial NN, Korsmeyer SJ (2004) Cell death: critical control points. Cell 116:205–219
Deavall DG, Martin EA, Horner JM, Roberts R (2012) Drug-induced oxidative stress and toxicity. J Toxicol 2012:645460
Demain AL (2009) Antibiotics: natural products essential to human health. Med Res Rev 29:821–842
dos Santos NA, Carvalho Rodrigues MA, Martins NM, dos Santos AC (2012) Cisplatin-induced nephrotoxicity and targets of nephroprotection: an update. Arch Toxicol 86:1233–1250
Elmore S (2007) Apoptosis: a review of programmed cell death. Toxicol Pathol 35:495–516
Freyssinet JM (2003) Cellular microparticles: what are they bad or good for? J Thromb Haemost 1(7):1655–1662
Garrido C, Galluzzi L, Brunet M, Puig PE, Didelot C, Kroemer G (2006) Mechanisms of cytochrome c release from mitochondria. Cell Death Differ 13:1423–1433
George JN, Aster RH (2009) Drug-induced thrombocytopenia: pathogenesis, evaluation, and management. Hematol Am Soc Hematol Educ Program 2009:153–158
Gupta A, Biyani M, Khaira A (2011) Vancomycin nephrotoxicity: myths and facts. Neth J Med 69:379–383
Hengartner MO (2000) The biochemistry of apoptosis. Nature 407:770–776
Italiano JE Jr, Mairuhu AT, Flaumenhaft R (2010) Clinical relevance of microparticles from platelets and megakaryocytes. Curr Opin Hematol 17:578–584
Kim YK, Kim HJ, Kwon CH, Kim JH, Woo JS, Jung JS, Kim JM (2005) Role of ERK activation in cisplatin-induced apoptosis in OK renal epithelial cells. J Appl Toxicol 25:374–382
Knijff-Dutmer EA, Koerts J, Nieuwland R, Kalsbeek-Batenburg EM, van de Laar MA (2002) Elevated levels of platelet microparticles are associated with disease activity in rheumatoid arthritis. Arthr Rheum 46:1498–1503
Leytin V (2012) Apoptosis in the anucleate platelet. Blood Rev 26:51–63
Li X, Cong H (2009) Platelet-derived microparticles and the potential of glycoprotein IIb/IIIa antagonists in treating acute coronary syndrome. Tex Heart Inst J 36:134–139
Li J, Xia Y, Bertino AM, Coburn JP, Kuter DJ (2000) The mechanism of apoptosis in human platelets during storage. Transfusion 40:1320–1329
Li S, Wang Z, Liao Y, Zhang W, Shi Q, Yan R, Ruan C, Dai K (2010) The glycoprotein Ib alpha-von Willebrand factor interaction induces platelet apoptosis. J Thromb Haemost 8:341–350
Lin KH, Hsiao G, Shih CM, Chou DS, Sheu JR (2009) Mechanisms of resveratrol-induced platelet apoptosis. Cardiovasc Res 83:575–585
López JJ, Redondo PC, Salido GM, Pariente JA, Rosado JA (2009) N,N,N′,N′-tetrakis (2-pyridylmethyl) ethylenediamine induces apoptosis through the activation of caspases-3 and -8 in human platelets: a role for endoplasmic reticulum stress. J Thromb Haemost 7:992–999
Mallat Z, Tedgui A (2001) Current perspective on the role of apoptosis in atherothrombotic disease Circ. Res 88:998–1003
Marinho DS, Huf G, Ferreira BL, Castro H, Rodrigues CR, de Sousa VP, Cabral LM (2011) The study of vancomycin use and its adverse reactions associated to patients of a Brazilian university hospital. BMC Res Notes 4:236
Marković SD, Djačić DS, Cvetković DM, Obradović AD, Žižić JB, Ognjanović BI, Štajn AŠ (2011) Effects of acute in vivo cisplatin and selenium treatment on hematological and oxidative stress parameters in red blood cells of rats. Biol Trace Elem Res 142:660–670
Mause SF, Weber C (2010) Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res 107:1047–1057
Meier P, Finch A, Evan G (2000) Apoptosis in development. Nature 407:796–801
Mintzer DM, Billet SN, Chmielewski L (2009) Drug-induced hematologic syndromes. Adv Hematol 2009:495863
Morel O, Jesel L, Freyssinet JM, Toti F (2011) Cellular mechanisms underlying the formation of circulating microparticles. Arterioscler Thromb Vasc Biol 31:15–26
Nelson ML, Levy SB (2011) The history of the tetracyclines. Ann N Y Acad Sci 1241:17–32
Nomura S, Nakamura T, Cone J, Tandon NN, Kambayashi J (2000) Cytometric analysis of high shear-induced platelet microparticles and effect of cytokines on microparticle generation. Cytometry 40:173–181
Nomura S, Omoto S, Yokoi T, Fujita S, Ozasa R, Eguchi N, Shouzu A (2011) Effects of miglitol in platelet-derived microparticle, adiponectin, and selectin level in patients with type 2 diabetes mellitus. Int J Gen Med 4:539–545
Olas B, Wachowicz B (2004) Resveratrol reduces oxidative stress induced by platinum compounds in blood platelets. Gen Physiol Biophys 23:315–326
Owens AP, Mackman N (2011) Microparticles in hemostasis and thrombosis. Circul Res 108:1284–1297
Pabla N, Dong Z (2008) Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int 73:994–1007
Packham MA (1994) Role of platelets in thrombosis and hemostasis. Can J Physiol Pharmacol 72:278–284
Patrono C, Rocca B (2009) Aspirin, 110 years later. J Thromb Haemost 7:258–261
Piccin A, Murphy WG, Smith OP (2007) Circulating microparticles: pathophysiology and clinical implications. Blood Rev 21:157–171
Pirro M, Schillaci G, Bagaglia F, Menecali C, Paltriccia R, Mannarino MR, Capanni M, Velardi A, Mannarino E (2008) Microparticles derived from endothelial progenitor cells in patients at different cardiovascular risk. Atherosclerosis 197:757–767
Pisetsky DS (2011) Platelet microparticles: making blood a bad humor. J Rheumatol 38:590–592
Plenchette S, Moutet M, Benguella M, N’Gondara JP, Guigner F, Coffe C, Corcos L, Bettaieb A, Solary E (2001) Early increase in DcR2 expression and late activation of caspases in the platelet storage lesion. Leukemia 15:1572–1581
Prasad KS, Andre P, He M, Bao M, Manganello J, Phillips DR (2003) Soluble CD40 ligand induces β3 integrin tyrosine phosphorylation and triggers platelet activation by outside-in signaling. Proc Natl Acad Sci USA 100:12367–12371
Preston RA, Jy W, Jimenez JJ, Mauro LM, Horstman LL, Valle M, Aime G, Ahn YS (2003) Effects of severe hypertension on endothelial and platelet microparticles. Hypertension 41:211–217
Ramesh G, Reeves WB (2005) p38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice. Am J Physiol Renal Physiol 289:F166–F174
Rand ML, Wang H, Bang KW, Teitel JM, Blanchette VS, Freedman J, Nurden AT (2010) Phosphatidylserine exposure and other apoptotic-like events in Bernard–Soulier syndrome platelets. Am J Hematol 85:584–592
Rautou PE, Vion AC, Amabile N, Chironi G, Simon A, Tedgui A, Boulanger CM (2011) Microparticles, vascular function, and atherothrombosis. Circ Res 109:593–606
Reese JA, Li X, Hauben M, Aster RH, Bougie DW, Curtis BR, George JN, Vesely SK (2010) Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods. Blood 116:2127–2133
Rocha JL, Kondo W, Baptista MI, Da Cunha CA, Martins LT (2002) Uncommon vancomycin-induced side effects. Braz J Infect Dis 6:196–200
Saraste A, Pulkki K (2000) Morphologic and biochemical hallmarks of apoptosis. Cardiovasc Res 45:528–537
Schilling A, Neuner E, Rehm SJ (2011) Vancomycin: a 50-something-year-old antibiotic we still don’t understand. Cleve Clin J Med 78:465–471
Shah RA, Musthaq A, Khardori NJ (2009) Vancomycin-induced thrombocytopenia in a 60-year-old man: a case report. Med Case Rep 3:7290
Sneader W (2000) The discovery of aspirin: a reappraisal. BMJ 321:1591–1594
Straface E, Gambardella L, Metere A, Marchesi A, Palumbo G, Cortis E, Villani A, Pietraforte D, Viora M, Malorni W, Del Principe D (2010) Oxidative stress and defective platelet apoptosis in naïve patients with Kawasaki disease. Biochem Biophys Res Commun 392:426–430
Suliman A, Lam A, Datta R, Srivastava RK (2001) Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways. Oncogene 20:2122–2133
Taguchi T, Nazneen A, Abid MR, Razzaque MS (2005) Cisplatin-associated nephrotoxicity and pathological events. Contrib Nephrol 148:107–121
Takano K, Asazuma N, Satoh K, Yatomi Y, Ozaki Y (2004) Collagen-induced generation of platelet-derived microparticles in whole blood is dependent on ADP released from red blood cells and calcium ions. Platelets 15:223–229
Terrisse AD, Puech N, Allart S, Gourdy P, Xuereb JM, Payrastre B, Sié P (2010) Internalization of microparticles by endothelial cells promotes platelet/endothelial cell interaction under flow. J Thromb Haemost 8:2810–2819
Towhid ST, Schmidt EM, Tolios A, Münzer P, Schmid E, Borst O, Gawaz M, Stegmann E, Lang F (2013a) Stimulation of platelet death by vancomycin. Cell Physiol Biochem 31:102–112
Towhid ST, Tolios A, Münzer P, Schmidt EM, Borst O, Gawaz M, Stegmann E, Lang F (2013b) Stimulation of platelet apoptosis by balhimycin. Biochem Biophys Res Commun 435:323–326
Tschuor C, Asmis LM, Lenzlinger PM, Tanner M, Härter L, Keel M, Stocker R, Stover JF (2008) In vitro norepinephrine significantly activates isolated platelets from healthy volunteers and critically ill patients following severe traumatic brain injury. Crit Care 12:R80
Tsuruya K, Ninomiya T, Tokumoto M, Hirakawa M, Masutani K, Taniguchi M, Fukuda K, Kanai H, Kishihara K, Hirakata H, Iida M (2003) Direct involvement of the receptor-mediated apoptotic pathways in cisplatin-induced renal tubular cell death. Kidney Int 63:72–82
VanWijk MJ, VanBavel E, Sturk A, Nieuwland R (2003) Microparticles in cardiovascular diseases. Cardiovasc Res 59:277–287
Von Drygalski A, Curtis BR, Bougie DW, McFarland JG, Ahl S, Limbu I, Baker KR, Aster RH (2007) Vancomycin-induced immune thrombocytopenia. N Engl J Med 356:904–910
Warner TD, Mitchell JA (2002) Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum? Proc Natl Acad Sci USA 99:13371–13373
Zahra S, Anderson JA, Stirling D, Ludlam CA (2011) Microparticles, malignancy and thrombosis. Br J Haematol 152:688–700
Zhang W, Zhao L, Liu J, Du J, Wang Z, Ruan C, Dai K (2012) Cisplatin induces platelet apoptosis through the ERK signaling pathway. Thromb Res 130:81–91
Zhao L, Zhang W, Chen M, Zhang J, Zhang M, Dai K (2013) Aspirin induces platelet apoptosis. Platelets 24(8):637–642
Conflict of interest
Authors declare that there exist no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Thushara, R.M., Hemshekhar, M., Kemparaju, K. et al. Therapeutic drug-induced platelet apoptosis: an overlooked issue in pharmacotoxicology. Arch Toxicol 88, 185–198 (2014). https://doi.org/10.1007/s00204-013-1185-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00204-013-1185-3